Natco Lenalid 15mg |Lenalidomide tablet-uses,side effects,dose,price in India


LENALID 15MG


lenalid 15mg tablet

ANTI- NEOPLASTIC 

DESCRIPTION

Lenalid 15mg contains Lenalidomide as an active substance which belongs to thalidomide analogue. Lenalid 15mg contains some pharmacological activities like immuno modulatory, anti-neoplastic, & anti-angiogenesis. Lenalid 15mg is available in various strengths like 5mg, 10mg, 15mg & 25mg. Lenalid 15mg is a prescription medicine; used under the supervision of medical oncologist. Lenalid 15mg is used by combining with dexamethasone.


The most common indications of Lenalid 15mg are; Multiple myeloma: Lenalid 15mg should be used in combination with dexamethasone. Myelodysplastic syndrome: Lenalid 15mg is used to treat this condition Mantle cell lymphoma: Lenalid 15mg is used for this condition, if patients are not responding to the Bortezomib treatment.


Lenalid 15mg tablet includes in the restraint of tumor rot factor alpha arrangement, which support the T-cells and causes lessening serum levels of cytokines vascular endothelial development factor and fundamental fibroblast development factor. Lenalid 15mg tablet is additionally engaged with the preclusion of angiogenesis. Lenalidomide is additionally empowered G1 cell cycle capture and apoptosis of ruinous cells.


LENALID 15MG TABLET
LENALID 15mg

Brand : Lenalid
Ingredients : Lenalidomide
Strength : 15mg
Manufactured : Natco
Package : 30 Tablets

DOSAGE MANAGEMENT

The usual prescribed dose of Lenalid in myelodysplastic syndromes is 10mg should be given as once a day. For renal damaged patients; In Patients with CrCl >60ml/min should not require dosage adjustment of Lenalid . In Patients with CrCl 30 to 60ml/min, 15mg of Lenalid should be given orally as once a day. In Patient with CrCl < 30ml/min, 2.15mg of Lenalid should be administered orally as a once a day. Dosage variation;THROMBOCYTOPENIA

Drops to <50000/mcL, therapy should be interrupted. Back to > or equal to 50000/mcL, continue the Lenalid of 15mg/day.NEUTROPENIA

Drops to <500/mcL, therapy should be postponed. Back to > or equal to 500/mcL, treatment should be continue to 15mg/day.MULTIPLE MYELOMA

In this condition, Lenalid is concomitant with dexamethasone. The usual dose of Lenalid is 215mg should be administered as once daily on day 1 to 21. The dose of dexamethasone; 40mg of dexamethasone should be followed on day 1 to 4, 9 to 12 & 17 to 20 of each 28 day cycles. Patient with >75 years, 20mg of dexamethasone should be recommended on day 1, 8, 15, & 22.MANTLE CELL LYMPHOMA

The advised dose of Lenalid for this condition is 215mg should be administered orally as once daily. For renal damaged patients; Patient with CrCl 30 to 60ml/min, 10mg of Lenalid should be administered as once daily. Patient with CrCl < 30ml/min, 115mg of Lenalid should be used for q48hr. Pediatrics; The potency & effectiveness of Lenalidomide has not been evaluated in pediatric patients with age of <18 years.

FOR MORE INFO

MOBILE NO : +91-9940472902

EMAIL : millionhealthpharmaceuticals@gmail.com

WEBSITE URL : https://millionpharma.com/lenalid-15mg.php

Comments

Popular posts from this blog

Pomalid 1mg Capsule Uses, Price, Side Effects, Composition, Substitutes,MRP, Cost India.

Pomahope 4mg capsules | Pomalidomide |Millionpharma

Bevacizumab Bevatas 100mg - Anticancer drugs | Intas | MHP